g g
PEG ν Х (trichosanthin TCS) C Й п Ю (legumain) п Х mPEG-Hz-Mal TCS-Asn10-Hz-PEG TCS-Asn10-Hz-PEG TCS-Asn10-Hz-PEG TCS-Asn10-Cys mPEG-Hz-Mal TCS-Asn10-Cys TCS-Asn10-Hz-PEG TCS-Asn10-Hz-PEG pH 5.6 п Ю TCS Х Х
ν pH п Ю
Ё R963 A 1007-7693(2014)11-1297-05 DOI: 10.13748/j.cnki.issn1007-7693.2014.11.001
1,2
2 2 2 2
1*
2*
(1. ┦ 610041 2.Ё
┦ 201203)
Constructed and Characterization of Tumor Microenvironment-sensitive Drug Delivery System
TAN Jiao1,2, CHEN Yingzhi2, LIN Tingting2, LIANG Jianming2, YANG Yongxin2, SUN Xun1*, HUANG Yongzhuo2*(1.West China School of Pharmacy, Sichuan University, Chengdu 610041, China; 2.Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, Shanghai 201203, China)
ABSTRACT: OBJECTIVE To achieve tumor microenvironment-sensitive drug delivery which was prepared by recombinant and PEGylation techniques. METHODS A substrate peptide sequence of asparaginyl endopeptidase (legumain) was introduced to the C-terminus of trichosanthin(TCS) by recombinant technique; the recombinant plasmid was transformed into E. coli BL21(DE3) competent cells. TCS-Asn10-Cys recombinant protein was expressed and purified according a standard protocol. Further, the C-terminus thiol of the recombinant protein was conjugated to mPEG-Hz-Mal. The TCS-Asn10-Hz-PEG conjugate was purified using CM sepharose fast flow column. The pH-sensitivity and enzyme-sensitivity of TCS-Asn10-Hz-PEG in vitro were tested. RESULTS The TCS-Asn10-Cys fusion protein was successfully expressed and purified. The tumor microenvironment-drug delivery system of TCS-Asn10-Hz-PEG was prepared. In either the pH 5.6 medium or the presence of legumain, the PEG chain could be cleaved by hydrolysis or proteolysis from the TCS, of which the activity was recovered. CONCLUSION It is developed a dual-sensitive drug delivery system of TCS-Asn10-Hz-PEG that can be responsive to either acidic hydrolysis or legumain proteolysis.
KEY WORDS: trichosanthin; PEGylation; tumor microenvironment; pH sensitive; legumain
21 Ё : ˇ 8% [1] (trichosanthin TCS) Ё
- (81422048, 81172996, 81373357)
╓ TCS TCS ч [2-4] TCS ▂L[5] ┑ TCS
Tel: (021)20231000-1403 E-mail: jiaotan1112@sina.cn * Tel: (028)85502307 E-mail: xunsun22@gmail.com Tel: (021)20231000-1401 E-mail: yzhuang@mail.shcnc.ac.cn
Ё 2014 11 31 11 Chin J Mod Appl Pharm, 2014 November, Vol.31 No.11 g1297g
我们还 进一步制备了双/多重刺激-响应载体系统。 ...制备了一系列具有环境敏感性的 智能给药系统,分别...(21125418)资助 HI-12 靶向肿瘤微环境的纳米药物...
的构建及其相应功能化纳米材料的设计、合成与表征 ...对肿瘤细胞 内特殊环境具有刺激响应性的纳米药物新...检测多药耐药转运蛋白、细胞 凋亡相关蛋白及其编码...
磁场-温度双重响应性复合微球的制备与表征_专业资料。采用部分还原共沉淀法制备了尺寸约为10nm的Fe3O4磁性纳米粒子,并用油酸对其进行表面改性,通过无皂乳液聚合的...
智能型高分子水凝胶结构表征的研究_工学_高等教育_...从结构上 探讨水凝胶的响应性是水凝胶研究中 的...通过观察探针的最大发射波长的瞬时变化发现微环境由...
4 Apr. ,2010 ·研究简报· 热磁双重响应性载药... 核 磁共振造影剂、 向药物载体和肿瘤磁过热疗法导...8 微囊的制备及表征 热磁敏感微 囊组装过程如图 ...
双温度响应性新型糖聚合物的合成与表征_专业资料。目前,对糖聚合物的研究引起了高分子科学及生物医药等领域的广泛关注[1,2],特别是具有温度响应性质的糖聚合物[...
响应性纳米控释系统等, 为构建 新型细胞微环境自...损失, 毒性甚至高于喜树碱(抗肿瘤药其物) 〔34〕...在智能药物释放系统的应用 ·2329· 是通过网格蛋白...
有效浓度 ,且药物 分布全身易致系统性毒副反应 。...[ 12 ] 等以水溶性药物 DOX 为模 型药 ,用双...DOX 白蛋白磁性纳米颗粒栓塞治疗大鼠原发 其抗肿瘤...
的构建及其相应功能化纳米材料的设计、合成与表征 ...对肿瘤细胞 内特殊环境具有刺激响应性的纳米药物新...检测多药耐药转运蛋白、细胞 凋亡相关蛋白及其编码...
型复合给药系统 制备和表征及其经口服抗肿瘤研究邓 ...以具有广谱抗肿瘤活性并为 P 糖蛋白 (P-gp) ...发展相关微环境 予以系统性干预 , 有望降低肿瘤转移...
热门文档